STOCK TITAN

Phreesia - PHR STOCK NEWS

Welcome to our dedicated page for Phreesia news (Ticker: PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia stock.

Overview of Phreesia Inc

Phreesia Inc is a comprehensive provider of software solutions engineered to enhance the operational and financial performance of healthcare organizations. Operating on a robust SaaS platform, the company specializes in streamlining essential processes that include patient access, registration, payments, appointment scheduling, and post-appointment surveys. By leveraging advanced digital technology, Phreesia empowers healthcare providers to optimize workflows, thereby improving patient engagement and ensuring that administrative and clinical operations are seamlessly integrated.

Core Business and Operational Model

At its core, Phreesia Inc addresses critical challenges in healthcare administration by offering a flexible, scalable platform designed to reduce the burden of routine tasks. This integrated suite of services activates patient engagement from the initial point of contact and continues through the entire care cycle. The platform is built to support a wide range of healthcare settings, from small medical groups to large healthcare systems, delivering a tailored experience that enhances efficiency without compromising the quality of care. The subscription-based model ensures consistent service delivery and allows for ongoing updates that adhere to evolving industry standards.

Key Features and Technologies

Phreesia's platform is characterized by its comprehensive range of functionalities:

  • Patient Access and Registration: Simplifies the onboarding process by providing digital forms and secure data collection methods.
  • Appointment Scheduling: Enhances the patient journey through intuitive scheduling features and automated reminders.
  • Payment Processing: Streamlines financial transactions, reducing administrative overhead and improving revenue cycle management.
  • Clinical Support Services: Provides tools that facilitate post-appointment feedback to further refine the quality of care delivered.

By integrating these features, Phreesia not only reduces repetitive administrative tasks but also promotes a more patient-centric approach that can translate into improved health outcomes.

Market Position and Industry Significance

In a competitive landscape where healthcare organizations face constant pressure to enhance operational efficiency while maintaining high standards of patient care, Phreesia has established itself as a resilient player by focusing on core operational streamlining. The company’s digital-first approach supports healthcare providers in managing patient flow more effectively, ultimately freeing up resources to focus on clinical excellence. Its ability to integrate seamlessly within diverse operational setups has made it a favored solution among healthcare organizations that prioritize both administrative efficiency and improved patient satisfaction.

Competitive Differentiation

What sets Phreesia apart is its deep expertise in the nuances of healthcare workflows combined with a commitment to technological innovation. Rather than offering a one-size-fits-all solution, Phreesia’s platform is designed to adapt to the specific needs of its clients. Its emphasis on a flexible, scalable approach, along with continuous service improvements, reinforces its reputation as an unbiased and dependable resource within the healthcare technology sector.

Comprehensive Integration and User Experience

Phreesia’s integrated approach ensures that both patients and healthcare providers benefit from a streamlined experience. By consolidating critical aspects of patient interaction into a single, comprehensive platform, the company simplifies the complexities typically associated with healthcare administration. This not only enhances the overall user experience but also fosters an environment where healthcare staff can dedicate more time to direct patient care, thereby driving tangible operational improvements.

Summary

In summary, Phreesia Inc is a key contributor within the healthcare technology landscape, offering a robust SaaS-based platform that redefines patient interaction and administrative efficiency. Its integrated solutions are designed to address the multifaceted challenges of healthcare management while establishing a secure, efficient, and user-friendly system that benefits all stakeholders involved.

Rhea-AI Summary
Phreesia's Vice President of Client Solutions, Audrey Gato, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2023, marking the sixth consecutive year a female leader from Phreesia has been recognized. Gato's role involves overseeing client implementation and account management for Phreesia’s payer and managed service offerings, as well as leading client efforts around clinical programs such as the Kidney Care Choices (KCC) Model and Merit-based Incentive Payment System (MIPS). The Software Report highlighted the diverse leadership roles of the award recipients, emphasizing their adept leadership within the SaaS industry. Gato expressed her honor in being recognized and emphasized Phreesia's commitment to introducing new initiatives and products to serve clients and the healthcare industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.75%
Tags
none
-
Rhea-AI Summary
Phreesia (PHR) has been recognized by PM360 for its innovative medication adherence solution, Post-Script Engagement, being named to the list of 2023 Most Innovative Marketing Technologies or Services. The offering was selected as one of 56 overall honorees, and one of just 8 technologies or services to be recognized for marketing innovation. Post-Script Engagement provides patients with resources to adhere to their medication as soon as their prescription is written, delivering curated content in a secure manner. The engagement also includes a survey to measure patients' likelihood to fill their prescription, providing insights to help doctors tailor their interactions with patients to address their unique adherence challenges. Phreesia's VP of Product Management, Kristin Roberts, expressed pride in offering Post-Script Engagement as part of a medication adherence product suite that supports patients, providers, and life sciences partners.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.05%
Tags
none
-
Rhea-AI Summary
Phreesia, Inc. (NYSE: PHR) announced its fiscal third-quarter results, reporting total revenue of $91.6 million, a 25% increase from the previous year. The net loss was $31.9 million, down from $40.2 million in the prior year. The company acquired ConnectOnCall.com, LLC for $13.9 million and replaced its credit facility with a new 5-year $50 million senior secured asset-based revolving credit facility with Capital One, N.A. Phreesia is maintaining its revenue outlook for fiscal year 2024 at $353 million to $356 million, with a year-over-year growth of 26% to 27%. The company is introducing its revenue outlook for fiscal 2025, expecting revenue to be in the range of $424 million to $434 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.22%
Tags
Rhea-AI Summary
Phreesia (PHR) is pleased to announce that the Centers for Medicare and Medicaid Services (CMS) has included the Patient Activation Measure Performance Measure (PAM-PM) in its Merit-Based Incentive Payment System (MIPS), as well as in 15 specialty-specific measure sets and five MIPS Value Pathways (MVPs), subsets of measures for specific conditions. The PAM measures a patient’s knowledge, skills, and confidence to self-manage their health. The measure steward of the PAM is Insignia Health, a wholly owned subsidiary of Phreesia. The PAM is used to support patients in taking a more active role in their care, driving better outcomes, especially for patients who need it most. The PAM has been included as a high priority outcome measure in the 2024 Medicare Physician Fee Schedule published by CMS. This move demonstrates CMS's commitment to person-centered care and health equity. The PAM has been developed nearly two decades ago and has been backed by a large body of research, with more than 800 peer-reviewed studies demonstrating its unique value. Beginning in 2024, MIPS-participating providers can report on gains in patient activation as a new quality measure, showcasing the importance of the PAM in understanding patients, allocating resources efficiently, and getting patients the support they need.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.11%
Tags
none
-
Rhea-AI Summary
Phreesia (PHR) Achieves HITRUST Risk-based Certified Status for Patient Intake Platform and Data Centers, Demonstrating High Information Security Standards and Compliance
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.45%
Tags
none
-
Rhea-AI Summary
Phreesia, Inc. (NYSE: PHR) will release its fiscal third quarter 2024 financial results on December 5, 2023. The results will be announced through a press release and quarterly stakeholder letter on the company's investor website. A conference call to discuss the results will be held at 5PM Eastern Time on the same day. A replay of the call will be available for on-demand listening.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.95%
Tags
Rhea-AI Summary
Phreesia Inc. reports Q2 2023 financial results. Total revenue increased by 26% to $85.8 million. Net loss decreased to $36.8 million. Cash and cash equivalents decreased to $127.7 million. Acquired MediFind for $9.0 million and Access eForms for $38.4 million. Maintaining revenue outlook for FY2024 at $353-356 million. Raising Adjusted EBITDA outlook to negative $54-49 million. Maintaining $500 million revenue target for FY2025. Expecting profitability in FY2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.11%
Tags
-
Rhea-AI Summary
Phreesia has been selected as one of the 'Top 100 Software Companies of 2023' by The Software Report. The evaluation is based on factors like product functionality, innovative capabilities, ESG involvement, and long-term viability. This is the second consecutive year that Phreesia has made the list. Other awardees include Adobe, Groove, and Pantheon.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.38%
Tags
none
-
Rhea-AI Summary
Phreesia, Inc. has approved the grant of restricted stock unit awards to 24 new non-executive employees. The awards, totaling 12,285 shares of common stock, were made on August 15, 2023, in accordance with the 2023 Inducement Award Plan. The awards will vest annually over a four-year period, subject to continued employment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.38%
Tags
Rhea-AI Summary
Phreesia (PHR) has acquired Access eForms, an electronic forms management provider, to enhance its patient intake, outreach, and activation services for healthcare organizations. Access eForms brings expertise in delivering thousands of forms used in healthcare settings and has seamless integrations with leading EHRs, including MEDITECH. The acquisition aims to help hospitals streamline workflows, improve compliance, and deliver a better patient experience, in line with Phreesia's focus on making care more convenient and patient-centered.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.93%
Tags

FAQ

What is the current stock price of Phreesia (PHR)?

The current stock price of Phreesia (PHR) is $21.97 as of March 10, 2025.

What is the market cap of Phreesia (PHR)?

The market cap of Phreesia (PHR) is approximately 1.3B.

What core services does Phreesia Inc provide?

Phreesia Inc offers a comprehensive SaaS-based platform that streamlines patient access, registration, appointment scheduling, payment processing, and clinical support, ensuring efficient healthcare operations.

How does Phreesia improve healthcare operations?

By integrating critical administrative and clinical processes into one platform, Phreesia reduces repetitive tasks and enhances patient engagement, allowing healthcare staff to focus more on patient care.

What is the primary business model of Phreesia Inc?

Phreesia operates on a subscription-based software model that provides continuous updates and support, ensuring that healthcare organizations receive a scalable, flexible solution tailored to their needs.

In what ways does Phreesia support financial operations in healthcare?

The platform streamlines payment processing and revenue cycle management, reducing administrative burdens and improving the financial performance of healthcare organizations.

How does Phreesia differentiate itself from competitors?

Phreesia distinguishes itself through its comprehensive integration of administrative and clinical functions, a highly adaptable platform, and a focused commitment to enhancing both operational efficiency and patient experience.

Who can benefit from using Phreesia's solutions?

Healthcare organizations of various sizes, including small medical groups and larger health systems, can benefit from Phreesia's flexible and scalable technology that improves patient access and overall operational performance.

What technology underpins Phreesia's platform?

The platform is built on advanced SaaS technology that incorporates digital data collection, automated appointment scheduling, secure payment processing, and tools for maintaining clinical quality through patient feedback.

How does Phreesia enhance patient engagement?

By seamlessly integrating patient registration, appointment scheduling, and feedback mechanisms, Phreesia improves the overall patient experience and ensures that patient engagement is sustained throughout the care cycle.
Phreesia

NYSE:PHR

PHR Rankings

PHR Stock Data

1.30B
55.13M
4.62%
100.81%
5.07%
Health Information Services
Services-business Services, Nec
Link
United States
WILMINGTON